article thumbnail

Why SAP ERP Makes Sense for Pharmaceutical Manufacturing

Navigator SAP

Legacy software systems no longer make sense for life sciences businesses, especially those in Pharmaceutical manufacturing. The problem is that complexity, regulation, and competition have changed how pharmaceutical and life sciences firms must do business. Data is siloed, hard to update, and time-consuming to store or use.

article thumbnail

Bed Bath & Beyond, Coinbase, Virgin Orbit and more

CFO News Room

Regeneron Pharmaceuticals — The stock was up 2.9%, a day after the shares dropped about 7.7% on news that sales of the pharmaceutical company’s Eylea drug were hurt by a shift to an off-label competitor in the final quarter of 2022. Agilent also said it was investing $725 million to double manufacturing capacity.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Govt to introduce incentive scheme to boost R&D by pharma industry: DCGI Somani

CFO News

PLI scheme aims to give companies incentives on incremental sales from products manufactured in domestic units. Somani was speaking on the first day of the 72nd Indian Pharmaceutical Congress in Nagpur.

article thumbnail

Managing Your Company’s Inventory

CFO Simplified

But if your business doesn’t have shelves in a warehouse filled with products for sale, you might think that you don’t need to worry about all of the issues and problems that go along with managing, protecting and selling that inventory. It doesn’t matter if you’re a manufacturer, a restaurant, or a law firm.

article thumbnail

Stocks Drop as Jobs Report Increases Rate-Hike Jitters

CFO News Room

HIG ), and Regeneron Pharmaceuticals, Inc. The maker of disinfectant wipes and other cleaning products said that higher-than-expected commodity prices and manufacturing costs cut into profit margins. PINS ) are jumping as the company posted its first annual profit and hit $2 billion in sales. Bureau of Labor Statistics.

article thumbnail

Uber, Abiomed, Peloton, Carvana, Molson Coors and more

CFO News Room

Pfizer – Shares of the pharmaceutical giant jumped nearly 3% after the company reported stronger-than-expected earnings and issued an improved financial outlook. Pfizer said strong demand for its older drugs helped offset a drop in sales of its Covid-related products. Eli Lilly – The drug manufacturer dropped 4.8%

article thumbnail

Can Kodak’s Moment Last?

PYMNTS

The tailwind, of course, has been the announcement by the Trump administration that there’s a deal in place with the firm to manufacture some of the ingredients that find their way into generic drugs. Thus, in one fell swoop, the company is expanding facilities based in New York and Minnesota, creating a Kodak Pharmaceuticals operation.